Business Standard

Monday, January 06, 2025 | 06:21 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Essential medicines to get cheaper in India after the release of NLEM

The medicines listed in the NLEM are sold below a price ceiling fixed by the National Pharmaceutical Pricing Authority (NPPA)

Photo: iStock
Premium

Photo: iStock

Sohini Das Mumbai
With the release of the latest National List of Essential Medicines (NLEM), several essential medicines are set to get cheaper in India. These include anti-diabetic drugs like insulin glargine, anti-tuberculosis drugs like delamanid, and antiparasite like ivermectin. 

The medicines listed in the NLEM are sold below a price ceiling fixed by the National Pharmaceutical Pricing Authority (NPPA). Price rise for scheduled drugs is linked to the wholesale price index-based inflation. For non-scheduled drugs, companies can hike prices by up to 10 per cent every year. Scheduled drugs roughly constitute 17-18 per cent of the estimated Rs 1.6-trillion domestic pharma market.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in